E

Exalt Clinical Research, Inc. | Chula Vista, CA

Research site

(Unclaimed)

Location

303 H Street Suite 510, Chula Vista, California, United States of America

Site insights

Top conditions

Top treatments

ESK-001

AD109

Atomoxetine

E2086

Aroxybutynin

Zasocitinib

IHL-42X

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 8 total trials

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with...

Enrolling

Plaque Psoriasis

Drug: Zasocitinib

Drug: Placebo

A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis (ONWARD1)

The goal of this clinical trial is to learn if ESK-001 works to treat moderate to severe plaque psoriasis. The main questions it aims to answer are:*...

Active, not recruiting

Plaque Psoriasis

Drug: Placebo

Drug: Apremilast

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine

Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis (ONWARD3)

The objective of the ESK-001-018 long term extension is to evaluate the safety and efficacy of ESK-001 over time. The scientific questions it aims to...

Enrolling

Psoriasis

Severe Psoriasis

Drug: Open-Label ESK-001

Drug: Blinded ESK-001

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA (REPOSA)

The goal of this randomised, double-blind phase II/III clinical trial is to determine the safety and efficacy of IHL-42X in subjects with obstructive...

Active, not recruiting

Obstructive Sleep Apnea

Drug: Acetazolamide

Drug: IHL-42X Low Dose